Huadong Medicine (000963.SZ): The clinical trial application for the HDM2006 pharmaceutical has received approval from the USA FDA.

On January 13th, Glorunhui reported that Huadong Medicine (000963.SZ) announced that on January 10, 2025, its wholly-owned subsidiary Hangzhou Sino-American Huadong Pharmaceutical Co., Ltd. received notification from the USA Food and Drug Administration. The clinical trial application for the HDM2006 tablet, submitted by Sino-American Huadong, has been approved by the USA FDA to conduct Phase I clinical trials for the indication of advanced malignant tumors. The HDM2006 tablet is independently developed by Sino-American Huadong targeting HPK1 (Hematopoietic Progenitor Kinase-1).

Gelonghui FinanceJan 13 17:33

Express News | huadong medicine: Wholly-owned subsidiary sinomec huadong obtained approval for new drug clinical trials by the USA FDA.

BreakingsJan 13 17:31

Sinolink: The market's attention to the left reversal of the pharmaceutical sector is increasing, with a focus on the related Sector of respiratory infections.

The proportion of influenza and other respiratory infections continues to rise, and it is recommended to closely monitor the infectious disease situation.

Zhitong FinanceJan 13 11:36

Sinolink: Major policies have been released, innovation remains the most important direction. The pharmaceutical and healthcare Industry has entered a performance window, focusing on reversal expectations.

The market has entered the window period for annual and quarterly reports, and it is recommended to actively pay attention to the fundamental Bearish clearance of left-side symbols (such as some Medical Devices, Traditional Chinese Medicine, pharmacies, chain Medical, CXO, etc.) and the implementation of centralized procurement policies.

Zhitong FinanceJan 6 15:56

Huadong Medicine Subsidiary Gets Aproval for HDM1005 Weight Management Drug Clinical Trials

MT NewswiresJan 3 12:11

Huadong Medicine (000963.SZ) subsidiary HDM1005 injection has obtained the clinical trial approval notice.

Huadong Medicine (000963.SZ) announced that on December 31, 2024, its wholly-owned subsidiary Hangzhou...

Zhitong FinanceJan 2 19:35